164 related articles for article (PubMed ID: 4071433)
1. [Effect of glucocorticosteroid and cytotoxic therapy on the natural cytotoxicity in rheumatic diseases].
Aleksandrova EN; Nasonov EL
Ter Arkh; 1985; 57(8):34-7. PubMed ID: 4071433
[No Abstract] [Full Text] [Related]
2. [Pulse therapy in the complex treatment of severe forms of Sjögren's syndrome and disease].
Vasil'ev VI; Solov'ev SK; Simonova MV; Safonova TN; Nasonov EL
Ter Arkh; 1986; 58(7):117-22. PubMed ID: 3764727
[TBL] [Abstract][Full Text] [Related]
3. [Antibody-dependent and natural cellular cytotoxic reactions in rheumatic diseases].
Aleksandrova EN; Zimin IuI; Nasonov EL
Ter Arkh; 1984; 56(10):130-6. PubMed ID: 6084315
[No Abstract] [Full Text] [Related]
4. [Inhibitory effect of sera from patients with rheumatic diseases on EA-rosette formation].
Nasonov EL; Aleksandrova EN; Sura VV; Ivanova MM; Zimin IuI
Ter Arkh; 1983; 55(7):32-7. PubMed ID: 6604958
[No Abstract] [Full Text] [Related]
5. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
Ebo D; DeClerck LS; Bridts CH; Stevens WJ
In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
[TBL] [Abstract][Full Text] [Related]
6. [Prospects of the use of cyclosporin A in rheumatic diseases].
Nasonov EL; Shtutman VZ; Nasonova VA
Klin Med (Mosk); 1994; 72(5):12-9. PubMed ID: 7853807
[No Abstract] [Full Text] [Related]
7. Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases.
Feldmann JL; Becker MJ; Moutsopoulos H; Fye K; Blackman M; Epstein WV; Talal N
J Clin Invest; 1976 Jul; 58(1):173-9. PubMed ID: 6490
[TBL] [Abstract][Full Text] [Related]
8. [Increased numbers of large granular lymphocytes in the peripheral blood in selected inflammatory rheumatic diseases].
Rovenský J; Tóth J; Rauová L; Lukác J; Zlnay D
Vnitr Lek; 1991 Jun; 37(6):572-7. PubMed ID: 1897139
[TBL] [Abstract][Full Text] [Related]
9. [Humoral reactivity against the secretory component of secretory IgA in rheumatoid arthritis, Sjögren's syndrome and systemic lupus erythematosus].
Luft S; Brzezińska B; Wójcik-Scisłowska M; Małdykowa H; Pazdur J; Strauss MM
Reumatologia; 1979; 17(2):137-43. PubMed ID: 472524
[No Abstract] [Full Text] [Related]
10. A critical review of the effect of levamisole in rheumatic diseases other than rheumatoid arthritis.
Rosenthal M
J Rheumatol Suppl; 1978; 4():97-100. PubMed ID: 366146
[TBL] [Abstract][Full Text] [Related]
11. [Combination of rituximab with combined pulse-therapy with high doses of methylprednisolone and cyclophosphamide: effects on immunomorphological and functional disturbances of the salivary glands in a patient with Sjogren's disease and MALT-lymphoma].
Vasil'ev VI; Kokosadze NV; Logvinenko OA; Nikitin EA; Mitrikov BV; Rodionova EB; Varlamova EIu
Ter Arkh; 2008; 80(5):76-9. PubMed ID: 18590121
[No Abstract] [Full Text] [Related]
12. [Immunologic background of overlap syndrome--studies on cellular immunity].
Horiuchi A; Irimajiri K; Miki T; Nishida M
Nihon Rinsho; 1976 Jun; 34(6):1183-8. PubMed ID: 787584
[No Abstract] [Full Text] [Related]
13. [Ribosomal protein L7 as an autoantigen in patients with systemic lupus erythematosus, mixed collagen disease and rheumatoid arthritis].
von Mikecz A; Hemmerich P; Neu E; Peter HH; Krawinkel U
Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):501-3. PubMed ID: 7856252
[No Abstract] [Full Text] [Related]
14. [The lung in connectivitis].
Schettini A; Iones F; D'Andrea A; Pucino A; Vatrella A; Marsico SA
Arch Monaldi; 1984; 39(1-2):3-26. PubMed ID: 6398036
[No Abstract] [Full Text] [Related]
15. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
16. [Basic immunologic indices and their significance in the diagnosis of rheumatic diseases. II. Analysis of immunologic indices in individual rheumatic diseases].
Timofeev VT
Revmatologiia (Mosk); 1983; (4):48-54. PubMed ID: 6366975
[No Abstract] [Full Text] [Related]
17. [Clinical relevance of antiphospholipid antibodies in rheumatology].
Gromnica-Ihle E; Franz J
Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):525-9. PubMed ID: 7856256
[No Abstract] [Full Text] [Related]
18. Antibodies to cytoplasmic intermediate filaments in rheumatic diseases.
Kurki P; Helve T; Virtanen I
J Rheumatol; 1983 Aug; 10(4):558-62. PubMed ID: 6352937
[TBL] [Abstract][Full Text] [Related]
19. [The treatment of collagen diseases].
Calin A
Internist (Berl); 1980 Nov; 21(11):697-701. PubMed ID: 7005164
[No Abstract] [Full Text] [Related]
20. Lymphocytes' cytotoxicity towards cells of human lymphoblastoid lines in patients with rheumatoid arthritis and systemic lupus erythematosus.
Skurkovich SV; Skorikova AS; Dubrovina NA; Riabova TV; Eremkina EI; Golodnenkova VN; Klinova EG; Olshanski AJ; Shurlapova NF
Ann Allergy; 1977 Nov; 39(5):344-50. PubMed ID: 921001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
